- AdventHealth Research Institute
It does not get much bigger than the summer of 2024 for the U.S. Men’s National Soccer Team (USMNT). The squad starts July by competing in the Copa America Tournament against South America’s top national teams. Team USA ends the month in the 2024 Summer Olympic games with a match against host country France.
One of the physicians keeping the team healthy is Dr. Daryl Osbahr, executive medical director of the AdventHealth Orthopedic Institute and chief of orthopaedic surgery for Rothman Orthopaedics Florida. “To be able to be involved in U.S. sports and represent your country, (there) is no greater honor,” said Osbahr.
Dr. Osbahr has been part of the team’s medical staff for more than a decade as both a team orthopedic surgeon and team physician. He says he treats everything from lower extremity injuries to simple medical issues that might send you to your general practitioner.
“You are the doctor. You (have to) be able to provide more care than just orthopedics. You have to be there to provide a host of different pathologies that might present themselves,” said Dr. Osbahr.
Dr. Osbahr shared insight on what it’s like to provide Whole Person care to these world-class athletes with Amy Kaufeldt on FOX 35 Orlando’s Good Day Orlando newscast. Click HERE to watch.
Recent News
Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of...
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health
Results From IGNITE Research Study Published in the Medical Journal "Age and Ageing"
“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...
NKGen Biotech today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel.
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
The AdventHealth Cancer Institute has been recognized in Becker's Hospital Review as one of the top 100 hospitals and health systems in the country for its excellence in oncology.
Dr. Wassim McHayleh featured in article about breast cancer research.
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.
Dr. Patricia Robinson has received has been named one of 50 Most Influential Clinical Executives in 2024 by Modern Healthcare.